Survivor

Megan Sharratt, native Idahoan and local artist, brings a caring and unique voice to the conversation on cancer survivorship. Diagnosed with Stage II Classical Hodgkin's Lymphoma (B type) in September 2024 two years of serious illness. Megan underwent six months of aggressive ABVD chemotherapy and has been in remission since May 2025.Through lived experience, Megan has developed a deep understanding of what survivorship truly entails, the challenges that come after "active treatment" ends, and the importance of compassionate, individualized care. Her expertise lies in building support systems for cancer survivors, helping both patients and providers understand that healing extends far beyond remission Megan is passionate about helping other survivors live their best lives, encouraging open dialogue, empathy, and awareness.